Luke Rynehart has a background in health technology assessments and economic modelling within the Australian public health system. His recent research focuses on long-term health outcomes and cost impacts of genomic technologies
Deborah Schofield, Luke Rynehart, Rupendra Shresthra, Susan M White, Zornitza Stark (2019) Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management and reproductive outcomes. GIM Open published online May 2019 DOI: 10.1038/s41436-019-0534-x
Zornitza Stark, Deborah Schofield, Melissa Martyn, Luke Rynehart, Rupendra Shrestha, Khurshid Alam, Sebastian Lunke, Tiong Y Tan, Clara L Gaff, Susan M White (2019) Does genomic sequencing early in the diagnostic trajectory make a difference? A follow up study of clinical outcomes and cost effectiveness. Genetics in Medicine 21(1), 173 (E-pub ahead of print – 29 August 2018).
Grants and Funding
Louisa Gordon, Nicholas Grave, Penelope Webb, Deborah Schofield, Rupendra Shrestha, Khurshid Alam, Owen Tan, Luke Rynehart, Sharyn Lymer, Sarah West (2017) Evaluation of clinical genomics projects in action. Queensland Genomics Health Alliance (QGHA) Round 1 Project Fund. $480,000 over 2 years.